|
Sep 26
|
Encompass Health Opens 9th Hospital in SC: More in the Pipeline?
|
|
Aug 29
|
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?
|
|
May 11
|
Earnings Update: Here's Why Analysts Just Lifted Their CareDx, Inc (NASDAQ:CDNA) Price Target To US$13.80
|
|
May 10
|
CareDx Reports Mixed Q1 2024 Results; Raises Annual Revenue Guidance
|
|
May 10
|
CareDx, Inc (NASDAQ:CDNA) Q1 2024 Earnings Call Transcript
|
|
May 9
|
CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 9
|
CareDx Reports First Quarter 2024 Results
|
|
May 7
|
CareDx (CDNA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
|
May 3
|
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
|
Apr 29
|
CareDx to Report First Quarter 2024 Financial Results
|
|
Apr 19
|
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
|
|
Apr 18
|
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
|
|
Apr 16
|
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
|
|
Apr 9
|
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
|
|
Apr 1
|
How CareDx (CDNA) Stock Stands Out in a Strong Industry
|
|
Mar 11
|
CareDx Appoints Bryan Riggsbee to Its Board of Directors
|
|
Jan 11
|
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
|
|
Jan 9
|
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
|
|
Dec 19
|
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
|
|
Dec 8
|
How Much Upside is Left in CareDx (CDNA)? Wall Street Analysts Think 26.72%
|